Explore 6 job-ready courses from Great Learning Academy Pro+ in collaboration with Microsoft. Learn Excel, SQL, Power BI, and ...

Pulse Biosciences, Inc. (Nasdaq: PLSE), pioneer of the novel nPulse™ platform using proprietary Nanosecond Pulsed Field Ablation (nsPFA™), today announced a new strategic alignment to prioritize and ...

Placebo-adjusted mean weight loss of 16.3% (39 lbs) at 180 mg and 16.0% (37 lbs) at 240 mg at 44 weeks with no evidence of weight loss plateau in ACCESS II, demonstrating highest efficacy among oral ...

AI has dominated commercial conversations for the past year. Nearly every major enterprise software vendor has announced an AI agent strategy, boards are asking how AI will boost productivity and, ...

Abstract: The effectiveness of dimension reduction analysis for high-dimensional process data is crucial to ensure industrial safety. Manifold learning methods can be advanced by considering both ...

India’s expanding renewable energy base and clean power can play a central role in supporting the next phase of data center growth, supported by smarter power sourcing, stronger grid readiness and ...

Enterprises still struggle to align governance, analytics, and AI despite years of data investment — that’s because what they really need is a structural reset of the data core itself that would unify ...

JACKSONVILLE, Fla.--(BUSINESS WIRE)-- Redwire Corporation (RDW), a global leader in space and defense technology solutions, today announced the sunsetting of the Edge Autonomy brand and full ...

Redwire Corporation (NYSE: RDW), a global leader in space and defense technology solutions, today announced the sunsetting of the Edge Autonomy brand and full assumption of uncrewed aerial systems ...

When voters move from emotional frustration to causal reasoning, elections follow. What’s also notable is what didn’t happen. Despite intense media coverage of foreign crises – Gaza, Syria, Venezuela ...

Amid an outpouring of obesity data Monday, Wave Life Sciences and Structure Therapeutics were among the biotechs jockeying to set their weight loss assets apart in an increasingly crowded field as ...

Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron. Structure Therapeutics' stock soared toward an 18-month high in early Monday trading, after mid-stage data for its ...